Diagnostics & Research
The Diagnostics & Research industry has a total of 58 stocks, with a combined market cap of $698.33 billion, total revenue of $158.36 billion and a weighted average PE ratio of 61.09.
Market Cap
698.33B
Revenue
158.36B
Profits
11.43B
PE Ratio
61.09
Profit Margin
7.22%
Dividend Yield
0.22%
58 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 196.16B | 0.73% | 1,511,825 | 42.37B |
| 2 | DHR | Danaher Corporation | 168.36B | 0.98% | 2,662,051 | 23.74B |
| 3 | A | Agilent Technologies, Inc. | 36.94B | 2.29% | 1,316,228 | 6.50B |
| 4 | IQV | IQVIA Holdings Inc. | 35.28B | 1.59% | 2,390,562 | 15.32B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 34.28B | 0.55% | 649,981 | 3.84B |
| 6 | MTD | Mettler-Toledo International Inc. | 24.62B | 0.54% | 240,002 | 3.76B |
| 7 | NTRA | Natera, Inc. | 22.16B | 3.57% | 1,962,546 | 1.53B |
| 8 | WAT | Waters Corporation | 21.24B | 3.79% | 686,784 | 2.91B |
| 9 | ILMN | Illumina, Inc. | 20.88B | -2.46% | 3,036,200 | 4.39B |
| 10 | LH | Labcorp Holdings Inc. | 19.89B | 0.69% | 481,695 | 12.71B |
| 11 | DGX | Quest Diagnostics Incorporated | 18.01B | 0.10% | 763,760 | 9.54B |
| 12 | ICLR | ICON Public Limited Company | 16.81B | 4.13% | 1,836,942 | 8.31B |
| 13 | RVTY | Revvity, Inc. | 13.55B | 1.30% | 951,685 | 2.72B |
| 14 | MEDP | Medpace Holdings, Inc. | 10.11B | 3.53% | 375,973 | 2.07B |
| 15 | EXAS | Exact Sciences Corporation | 9.75B | -2.26% | 2,134,288 | 2.69B |
| 16 | CRL | Charles River Laboratories International, Inc. | 9.61B | 0.97% | 636,063 | 4.06B |
| 17 | QGEN | Qiagen N.V. | 9.35B | 3.16% | 1,751,238 | 1.97B |
| 18 | RDNT | RadNet, Inc. | 6.08B | 2.89% | 547,175 | 1.77B |
| 19 | GH | Guardant Health, Inc. | 3.79B | - | 1,556,001 | 692.26M |
| 20 | SHC | Sotera Health Company | 3.74B | -2.94% | 2,406,449 | 1.12B |
| 21 | NEOG | Neogen Corporation | 3.23B | -1.26% | 1,184,629 | 912.20M |
| 22 | VCYT | Veracyte, Inc. | 3.04B | 0.13% | 631,375 | 425.33M |
| 23 | TWST | Twist Bioscience Corporation | 2.44B | -0.51% | 736,547 | 312.97M |
| 24 | NEO | NeoGenomics, Inc. | 1.97B | - | 371,677 | 644.12M |
| 25 | MYGN | Myriad Genetics, Inc. | 1.39B | 2.00% | 660,564 | 823.60M |
| 26 | CDNA | CareDx, Inc | 1.20B | 1.41% | 543,576 | 312.78M |
| 27 | OPK | OPKO Health, Inc. | 1.08B | -2.47% | 2,615,530 | 711.41M |
| 28 | CSTL | Castle Biosciences, Inc. | 796.81M | -1.45% | 302,277 | 311.88M |
| 29 | FLGT | Fulgent Genetics, Inc. | 528.54M | 1.65% | 248,770 | 277.76M |
| 30 | GRAL | GRAIL, Inc. | 507.04M | 2.03% | 478,043 | 117.67M |
| 31 | ACRS | Aclaris Therapeutics, Inc. | 282.87M | -13.73% | 5,737,712 | 27.08M |
| 32 | PSNL | Personalis, Inc. | 196.17M | -6.23% | 1,174,394 | 87.49M |
| 33 | BDSX | Biodesix, Inc. | 173.11M | -4.03% | 1,715,221 | 65.56M |
| 34 | FONR | FONAR Corporation | 95.29M | 0.88% | 11,692 | 102.01M |
| 35 | ME | 23andMe Holding Co. | 86.10M | -8.16% | 410,348 | 193.26M |
| 36 | NOTV | Inotiv, Inc. | 83.47M | 15.05% | 2,288,936 | 501.06M |
| 37 | MDXH | MDxHealth SA | 76.61M | 3.18% | 396,074 | 84.71M |
| 38 | VNRX | VolitionRx Limited | 74.60M | 20.90% | 307,231 | 1.29M |
| 39 | XGN | Exagen Inc. | 73.02M | 18.98% | 770,202 | 55.75M |
| 40 | PRE | Prenetics Global Limited | 57.67M | 5.83% | 14,639 | 22.66M |
| 41 | ENZ | Enzo Biochem, Inc. | 51.57M | -2.27% | 103,821 | 31.91M |
| 42 | BNR | Burning Rock Biotech Limited | 47.60M | 1.09% | 3,656 | 70.15M |
| 43 | OCX | OncoCyte Corporation | 46.30M | 7.84% | 25,347 | 709.00K |
| 44 | STIM | Neuronetics, Inc. | 24.35M | 6.26% | 504,649 | 72.71M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 19.79M | -4.51% | 198,421 | 9.37M |
| 46 | PRPH | ProPhase Labs, Inc. | 18.26M | 0.66% | 44,248 | 12.75M |
| 47 | PMD | Psychemedics Corporation | 13.79M | 0.86% | 26,766 | 20.26M |
| 48 | AWH | Aspira Women's Health Inc. | 11.73M | 2.46% | 51,230 | 8.96M |
| 49 | STRR | Star Equity Holdings, Inc. | 9.54M | 2.78% | 16,300 | 50.38M |
| 50 | TTOO | T2 Biosystems, Inc. | 9.50M | -4.39% | 359,829 | 7.68M |
| 51 | PRPO | Precipio, Inc. | 8.89M | - | 8,960 | 17.41M |
| 52 | APDN | Applied DNA Sciences, Inc. | 8.33M | -0.48% | 1,620,331 | 3.40M |
| 53 | XWEL | XWELL, Inc. | 7.83M | -0.67% | 3,303 | 33.83M |
| 54 | MYNZ | Mainz Biomed N.V. | 5.73M | 2.00% | 3,684,579 | 917.20K |
| 55 | CHEK | Check-Cap Ltd. | 4.46M | 0.08% | 7,605 | - |
| 56 | ISPC | iSpecimen Inc. | 4.44M | 3.60% | 67,137 | 10.39M |
| 57 | GENE | Genetic Technologies Limited | 3.78M | - | 17,539 | 6.45M |
| 58 | NDRA | ENDRA Life Sciences Inc. | 2.69M | 7.64% | 221,263 | - |